自身免疫病发病机制研究 Study on pathogenesis of autoimmune diseases

肿瘤免疫微环境研究 Study on tumor immune microenvironment

同济大学附属东方医院科创中心副主任

Deputy Chief of the Innovation and Technology Center, Shanghai East Hospital, Tongji University School of Medicine.

实验技术教研室主任

Director of experimental technology teaching department.

博士，副教授，主任技师，博士研究生导师。长期致力于自身免疫病的发病机制、肿瘤免疫微环境研究，探索从代谢途径诊疗疾病的新方法和新技术，主持国家自然科学基金、省部级自然科学基金、教育部重点项目培育项目等多项课题。2023年入选浦东新区学科带头人、2015年入选浦东新区优青等多项人才培养计划。近年来在Int Immunopharmacol（2024）、BMC Cancer（2022）、Arthritis Res Ther（2022）、J Cell Mol Med（2021）、Theranostics(2018)、Nature Communications（2017）等国际期刊发表研究成果，荣获上海市医学科技奖二等奖（2024）、上海市医学会优秀论文三等奖（2021）、浦东新区科技进步一等奖（2018）等奖励。

Lu Ying is a Doctor, Associate Professor, Chief Technician, and Doctoral Supervisor. Her primary research interests lie in the pathogenesis of autoimmune diseases and the tumor immune microenvironment. She is dedicated to exploring innovative methods and technologies for diagnosing and treating diseases by leveraging metabolic pathways. Dr. Lu Ying has been awarded several scientific research projects, including the National Natural Science Foundation, the Natural Science Foundation of Jiangxi Province, and the Key Cultivation Project of Tongji University. In 2023, she was selected as a subject leader in the Pudong New Area. In 2015, she was chosen for the Outstanding Young Medical Talents Training Program. Her research findings have been published in prestigious international journals such as International Immunopharmacology (2024), BMC Cancer (2022), Arthritis Research & Therapy (2022), Journal of Cellular and Molecular Medicine (2021), Theranostics (2018), and Nature Communications (2017). She has also received accolades, including the second prize of the Shanghai Medical Science and Technology Award (2024), the first prize of the Shanghai Pudong New Area Science and Technology Progress Award (2018), and the third prize of the Excellent Paper Award of the Shanghai Medical Association (2021).